The future of genomic profiling of neurological diseases using blood

Frank R Sharp, Huichun Xu, Lisa Lit, Wynn Walker, Michelle L Apperson, Donald L. Gilbert, Tracy A. Glauser, Brenda Wong, Andrew Hershey, Da Liu, Joseph Pinter, Xinhua Zhan, Xinshe Liu, Ruiqiong Ran

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Sequencing of the human genome and new microarray technology make it possible to assess all genes on a single chip or array. Recent studies show different patterns of gene expression related to different tissues and diseases, and these patterns of gene expression are beginning to be used for diagnosis and treatment decisions in various types of lymphoid and solid malignancies. Because of obvious problems obtaining brain tissue, progress in genomics of neurological diseases has been slow. To address this, we demonstrated that different types of acute injury in rodent brain produced different patterns of gene expression in peripheral blood. These animal studies have now been extended to human studies. Two groups have shown that there are specific genomic profiles in the blood of patients after ischemic stroke that are highly sensitive and specific for predicting stroke. Other recent studies demonstrate specific genomic profiles in the blood of patients with Down syndrome, neurofibromatosis, tuberous sclerosis, Huntington disease, multiple sclerosis, Tourette syndrome, and others. In addition, data demonstrate specific profiles of gene expression in the blood related to different drugs, toxins, and infections. Although all of these studies are still preliminary basic scientific endeavors, they suggest that this approach will have clinical applications to neurological diseases in humans.

Original languageEnglish (US)
Pages (from-to)1529-1536
Number of pages8
JournalArchives of Neurology
Volume63
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Hematologic Diseases
Gene Expression
Stroke
Tourette Syndrome
Neurofibromatoses
Tuberous Sclerosis
Huntington Disease
Brain
Human Genome
Genomics
Down Syndrome
Transcriptome
Multiple Sclerosis
Rodentia
Technology
Profiling
Neurological Disease
Blood
Wounds and Injuries
Infection

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The future of genomic profiling of neurological diseases using blood. / Sharp, Frank R; Xu, Huichun; Lit, Lisa; Walker, Wynn; Apperson, Michelle L; Gilbert, Donald L.; Glauser, Tracy A.; Wong, Brenda; Hershey, Andrew; Liu, Da; Pinter, Joseph; Zhan, Xinhua; Liu, Xinshe; Ran, Ruiqiong.

In: Archives of Neurology, Vol. 63, No. 11, 11.2006, p. 1529-1536.

Research output: Contribution to journalArticle

Sharp, FR, Xu, H, Lit, L, Walker, W, Apperson, ML, Gilbert, DL, Glauser, TA, Wong, B, Hershey, A, Liu, D, Pinter, J, Zhan, X, Liu, X & Ran, R 2006, 'The future of genomic profiling of neurological diseases using blood', Archives of Neurology, vol. 63, no. 11, pp. 1529-1536. https://doi.org/10.1001/archneur.63.11.1529
Sharp, Frank R ; Xu, Huichun ; Lit, Lisa ; Walker, Wynn ; Apperson, Michelle L ; Gilbert, Donald L. ; Glauser, Tracy A. ; Wong, Brenda ; Hershey, Andrew ; Liu, Da ; Pinter, Joseph ; Zhan, Xinhua ; Liu, Xinshe ; Ran, Ruiqiong. / The future of genomic profiling of neurological diseases using blood. In: Archives of Neurology. 2006 ; Vol. 63, No. 11. pp. 1529-1536.
@article{f2a49748815747f6a30cad23f03ecf26,
title = "The future of genomic profiling of neurological diseases using blood",
abstract = "Sequencing of the human genome and new microarray technology make it possible to assess all genes on a single chip or array. Recent studies show different patterns of gene expression related to different tissues and diseases, and these patterns of gene expression are beginning to be used for diagnosis and treatment decisions in various types of lymphoid and solid malignancies. Because of obvious problems obtaining brain tissue, progress in genomics of neurological diseases has been slow. To address this, we demonstrated that different types of acute injury in rodent brain produced different patterns of gene expression in peripheral blood. These animal studies have now been extended to human studies. Two groups have shown that there are specific genomic profiles in the blood of patients after ischemic stroke that are highly sensitive and specific for predicting stroke. Other recent studies demonstrate specific genomic profiles in the blood of patients with Down syndrome, neurofibromatosis, tuberous sclerosis, Huntington disease, multiple sclerosis, Tourette syndrome, and others. In addition, data demonstrate specific profiles of gene expression in the blood related to different drugs, toxins, and infections. Although all of these studies are still preliminary basic scientific endeavors, they suggest that this approach will have clinical applications to neurological diseases in humans.",
author = "Sharp, {Frank R} and Huichun Xu and Lisa Lit and Wynn Walker and Apperson, {Michelle L} and Gilbert, {Donald L.} and Glauser, {Tracy A.} and Brenda Wong and Andrew Hershey and Da Liu and Joseph Pinter and Xinhua Zhan and Xinshe Liu and Ruiqiong Ran",
year = "2006",
month = "11",
doi = "10.1001/archneur.63.11.1529",
language = "English (US)",
volume = "63",
pages = "1529--1536",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - The future of genomic profiling of neurological diseases using blood

AU - Sharp, Frank R

AU - Xu, Huichun

AU - Lit, Lisa

AU - Walker, Wynn

AU - Apperson, Michelle L

AU - Gilbert, Donald L.

AU - Glauser, Tracy A.

AU - Wong, Brenda

AU - Hershey, Andrew

AU - Liu, Da

AU - Pinter, Joseph

AU - Zhan, Xinhua

AU - Liu, Xinshe

AU - Ran, Ruiqiong

PY - 2006/11

Y1 - 2006/11

N2 - Sequencing of the human genome and new microarray technology make it possible to assess all genes on a single chip or array. Recent studies show different patterns of gene expression related to different tissues and diseases, and these patterns of gene expression are beginning to be used for diagnosis and treatment decisions in various types of lymphoid and solid malignancies. Because of obvious problems obtaining brain tissue, progress in genomics of neurological diseases has been slow. To address this, we demonstrated that different types of acute injury in rodent brain produced different patterns of gene expression in peripheral blood. These animal studies have now been extended to human studies. Two groups have shown that there are specific genomic profiles in the blood of patients after ischemic stroke that are highly sensitive and specific for predicting stroke. Other recent studies demonstrate specific genomic profiles in the blood of patients with Down syndrome, neurofibromatosis, tuberous sclerosis, Huntington disease, multiple sclerosis, Tourette syndrome, and others. In addition, data demonstrate specific profiles of gene expression in the blood related to different drugs, toxins, and infections. Although all of these studies are still preliminary basic scientific endeavors, they suggest that this approach will have clinical applications to neurological diseases in humans.

AB - Sequencing of the human genome and new microarray technology make it possible to assess all genes on a single chip or array. Recent studies show different patterns of gene expression related to different tissues and diseases, and these patterns of gene expression are beginning to be used for diagnosis and treatment decisions in various types of lymphoid and solid malignancies. Because of obvious problems obtaining brain tissue, progress in genomics of neurological diseases has been slow. To address this, we demonstrated that different types of acute injury in rodent brain produced different patterns of gene expression in peripheral blood. These animal studies have now been extended to human studies. Two groups have shown that there are specific genomic profiles in the blood of patients after ischemic stroke that are highly sensitive and specific for predicting stroke. Other recent studies demonstrate specific genomic profiles in the blood of patients with Down syndrome, neurofibromatosis, tuberous sclerosis, Huntington disease, multiple sclerosis, Tourette syndrome, and others. In addition, data demonstrate specific profiles of gene expression in the blood related to different drugs, toxins, and infections. Although all of these studies are still preliminary basic scientific endeavors, they suggest that this approach will have clinical applications to neurological diseases in humans.

UR - http://www.scopus.com/inward/record.url?scp=33751020244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751020244&partnerID=8YFLogxK

U2 - 10.1001/archneur.63.11.1529

DO - 10.1001/archneur.63.11.1529

M3 - Article

C2 - 17101821

AN - SCOPUS:33751020244

VL - 63

SP - 1529

EP - 1536

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 11

ER -